Actively Recruiting

Phase Not Applicable
Age: 6Years - 18Years
All Genders
NCT06685601

An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder

Led by Qilu Hospital of Shandong University · Updated on 2025-07-22

60

Participants Needed

2

Research Sites

123 weeks

Total Duration

On this page

Sponsors

Q

Qilu Hospital of Shandong University

Lead Sponsor

C

Capital Medical University

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study aims to intervene in children and adolescents with ADHD using transcranial photobiomodulation, comparing its effects on executive function at the levels of electroencephalography (EEG), eye tracking, and cognitive behavior. The goal is to identify the most effective clinical treatment strategy for ADHD patients.

CONDITIONS

Official Title

An Intervention Study on Transcranial Photobiomodulation in Children With Attention Deficit Hyperactivity Disorder

Who Can Participate

Age: 6Years - 18Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 6 and 18 years
  • Clinically diagnosed with ADHD by a psychiatrist
  • Meets DSM-5 criteria for ADHD confirmed by a child psychiatrist
  • M.I.N.I. KID interview shows only ADHD with no other comorbidities
  • Able to cooperate with transcranial photobiomodulation therapy
  • Participant and guardian understand study and provide signed informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of other severe mental illnesses such as schizophrenia or bipolar disorder
  • Severe physical diseases or conditions including intracranial lesions, thyroid disorders, epilepsy, congenital heart disease, hematologic disorders, lupus, or sensory impairments
  • Significant structural brain abnormalities on imaging
  • Severe neurological diseases with family history or risk
  • Metal implants, pacemaker, skull holes, or fractures
  • Currently receiving or stopped ADHD treatments less than 2 weeks ago
  • IQ score below 85 on Raven's Progressive Matrices

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Qilu Hospital of Shandong University

Jinan, Shandong, China, 250012

Not Yet Recruiting

2

Qilu Hospital of Shandong University

Jinan, Shandong, China, 250012

Actively Recruiting

Loading map...

Research Team

A

Aihua Cao, Post-doctoral

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here